UK tribunal denies excessive-pricing appeals
The UK’s Competition Appeal Tribunal has denied separate requests from the Competition and Markets Authority, Pfizer and Flynn Pharma to appeal against aspects of its phenytoin excessive-pricing decision last month, and ordered an immediate remittal of the case to the authority.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10